---
title: "ZENG XUEBO — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b36c0328-8215-53ee-9f80-eab8681c25bb
json: https://whiteintel.dev/api/public/dossier/b36c0328-8215-53ee-9f80-eab8681c25bb
identifier: sec:0002130011
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ZENG XUEBO

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002130011`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b36c0328-8215-53ee-9f80-eab8681c25bb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b36c0328-8215-53ee-9f80-eab8681c25bb  

## Ownership & control

### Holdings / subsidiaries

- **CASI PHARMACEUTICALS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/57c9fd36-d871-54e8-a3e6-7641a9ba063b

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ZENG XUEBO**. Human view: https://whiteintel.dev/entity/b36c0328-8215-53ee-9f80-eab8681c25bb · Structured JSON: https://whiteintel.dev/api/public/dossier/b36c0328-8215-53ee-9f80-eab8681c25bb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._